These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35042020)

  • 1. Cost of Illness of Multiple Sclerosis in Isfahan, Iran, From a Social Perspective: A Comparison of the Human-Capital and Friction-Cost Methods.
    Amirsadri M; Rahimi F; Khajepour A
    Value Health Reg Issues; 2022 Jul; 30():26-30. PubMed ID: 35042020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.
    Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T
    BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran.
    Ghaffari Darab M; Keshavarz K; Sadeghi E; Shahmohamadi J; Kavosi Z
    BMC Health Serv Res; 2021 Feb; 21(1):132. PubMed ID: 33573650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method.
    Hutubessy RC; van Tulder MW; Vondeling H; Bouter LM
    Pain; 1999 Mar; 80(1-2):201-7. PubMed ID: 10204732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friction cost approach methodology in pharmacoeconomic analyses.
    Grega D; Kolář J
    Ceska Slov Farm; 2021; 70(3):109-113. PubMed ID: 34418948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach.
    Hanly P; Ortega-Ortega M; Soerjomataram I
    Curr Oncol; 2022 May; 29(5):3552-3564. PubMed ID: 35621677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of multiple sclerosis in Slovakia - from 2015 to 2020.
    Babela R; Dugas J
    BMC Health Serv Res; 2022 Dec; 22(1):1467. PubMed ID: 36461018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the costs of illness of ankylosing spondylitis and methodologic notes.
    Boonen A; van der Heijde D
    Expert Rev Pharmacoecon Outcomes Res; 2005 Apr; 5(2):163-81. PubMed ID: 19807572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
    Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
    Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
    Iragorri N; de Oliveira C; Fitzgerald N; Essue B
    Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of productivity: human-capital versus friction-cost method.
    van den Hout WB
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i89-91. PubMed ID: 19995754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of a multiple sclerosis relapse: the patient's perspective.
    Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP
    Patient; 2012; 5(1):57-69. PubMed ID: 22217263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study.
    Akbari Sari A; Kazemi Karyani A; Alavian SM; Arab M; Rostami Gholmohamadi F; Rezaei S
    Iran J Public Health; 2015 Apr; 44(4):512-21. PubMed ID: 26056670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
    Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
    Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
    Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
    Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
    PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of illness of multiple sclerosis: Part I: Cost of illness. The Canadian Burden of Illness Study Group.
    Can J Neurol Sci; 1998 Feb; 25(1):23-30. PubMed ID: 9532277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of Illness of Multiple Sclerosis - A Systematic Review.
    Ernstsson O; Gyllensten H; Alexanderson K; Tinghög P; Friberg E; Norlund A
    PLoS One; 2016; 11(7):e0159129. PubMed ID: 27411042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach.
    Hanly P; Timmons A; Walsh PM; Sharp L
    Value Health; 2012 May; 15(3):429-36. PubMed ID: 22583452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.